Cargando…
Targeting the SUMO pathway for neuroprotection in brain ischaemia
Small ubiquitin-like modifier (SUMO) conjugation (SUMOylation) is a post-translational protein modification that modulates almost all major cellular processes, and has been implicated in many human diseases. A growing body of evidence from in vitro and in vivo studies demonstrates that increasing gl...
Autores principales: | Yang, Wei, Sheng, Huaxin, Wang, Haichen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435206/ https://www.ncbi.nlm.nih.gov/pubmed/28959470 http://dx.doi.org/10.1136/svn-2016-000031 |
Ejemplares similares
-
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
por: Kukkula, Antti, et al.
Publicado: (2021) -
SUMO2/3 conjugation is an endogenous neuroprotective mechanism
por: Datwyler, Anna Lena, et al.
Publicado: (2011) -
Emerging roles of the SUMO pathway in mitosis
por: Dasso, Mary
Publicado: (2008) -
Rhabdoviruses, Antiviral Defense, and SUMO Pathway
por: El Asmi, Faten, et al.
Publicado: (2018) -
The SUMO Pathway in Hematomalignancies and Their Response to Therapies
por: Boulanger, Mathias, et al.
Publicado: (2019)